20 novembre 2026
SDA Bocconi at WOBI: advancing health as a driver of growth and reducing inequalities
Rosanna Tarricone moderated the Health & Economy panel at the World Business Forum Milan 2026, exploring how innovation can contribute to economic growth and healthcare system sustainability.

Healthcare innovation is a driver of economic growth, but its value must also be measured by its ability to strengthen the public healthcare system and improve access to care. This was the perspective brought by SDA Bocconi School of Management to the World Business Forum Milan 2026, organized by WOBI. Rosanna Tarricone, Associate Dean of the Government, Health and Non Profit Division, moderated the Health & Economy panel, which explored health as a foundation for economic and social development.
The discussion began by examining the relationship between health and a country's capacity for growth. The pharmaceutical and medical technology industries drive research, exports, and high-skilled employment while attracting talent and investment. Beyond their industrial contribution, a healthy population is better able to participate in economic and social life. Assessing healthcare investments therefore also means considering their impact on productivity and long-term development.
This perspective must be considered alongside the growing pressures facing the Italian National Health Service (SSN). Population aging is increasing the demand for chronic care while shrinking the tax base that supports public healthcare funding. Workforce shortages and waiting lists are making it increasingly difficult to meet healthcare needs. Barriers to access and unmet healthcare needs are unevenly distributed across income levels, geographic areas, gender, and educational backgrounds, challenging the system's ability to uphold its universal coverage.
Public trust is also central to this relationship: the right to healthcare must translate into timely and appropriate access to services. Innovation must help strengthen the system's ability to respond, making the sustainability of public healthcare and the reduction of inequalities integral to the value it creates.
"Viewing health as a foundation for development means considering health outcomes, economic value creation, and the public healthcare system's ability to meet people's needs together. Innovation must contribute to making the Italian National Health Service sustainable and reducing inequalities in access to care. To achieve this, industry must act as a partner to the healthcare system, sharing responsibility for outcomes," said Rosanna Tarricone, Associate Dean of the Government, Health and Non Profit Division.
The panel brought together Claudia Georgia Banella, Vice President Southern Europe and Managing Director of KARL STORZ Endoscopia Italia; Federico Chinni, Managing Director of UCB Italia; Nicola Bencini, General Manager of Incyte Italia; and Flavia Binetti, Managing Director of Organon Italia.
The questions addressed to industry representatives connected this broader perspective to concrete priorities: the education and professional development of healthcare professionals, the assessment of medical technologies based on outcomes, the contribution of artificial intelligence to research and care pathways, and Italy's attractiveness as a destination for clinical trials. Prevention and women's health also brought attention to long-term benefits and inequalities in access to treatment.
These priorities must be addressed within the constraints that shape how innovation translates into healthcare services and patient care: limited resources, spending caps, payback mechanisms, and an evolving European regulatory framework covering pharmaceuticals, medical devices, artificial intelligence, and health data. How these regulations are implemented, and how companies operate within them, directly affects the availability of innovation.
This led to the moderator's closing question: what measure should the government introduce to shift the perception of healthcare from a cost to an investment, and what commitment should industry make in return? A question that connects industry's capacity to generate innovation with its responsibility to support the sustainability of the public healthcare system and ensure a more equitable distribution of its benefits.























